$Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center study$

Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center study

Background: Therapeutic plasma exchange (TPE) is frequently used in glucocorticosteroid (GCS)-refractory multiple sclerosis (MS) relapses. Data regarding predictors of treatment response are scarce. The objective of this study was to analyze predictive factors for response to TPE in GCS-refractory M...

Full description

Bibliographic Details
Main Authors:	Stephan Blechinger, Johannes Ehler, Gabriel Bsteh, Alexander Winkelmann, Fritz Leutmezer, Stefanie Meister, Agnes Santer, Michael Hecker, Thomas Berger, Paulus Rommer, Uwe Klaus Zettl
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-01-01
Series:	Therapeutic Advances in Neurological Disorders
Online Access:	https://doi.org/10.1177/1756286420975642

Similar Items

Rituximab mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
by: Tobias Zrzavy, et al.
Published: (2021-07-01)

Remote visits for people with multiple sclerosis during the COVID-19 pandemic in Austria: The TELE MS randomized controlled trial
by: Patrick Altmann, et al.
Published: (2022-07-01)

Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis
by: Michael Hecker, et al.
Published: (2021-10-01)

Vaccination in Multiple Sclerosis: Friend or Foe?
by: Tobias Zrzavy, et al.
Published: (2019-08-01)

Relapsing and progressive MS: the sex-specific perspective
by: Paulus Stefan Rommer, et al.
Published: (2020-09-01)

Predisposing Factors for Sexual Dysfunction in Multiple Sclerosis
by: Patrick Altmann, et al.
Published: (2021-02-01)

Estimating Risk of Multiple Sclerosis Disease Reactivation in Pregnancy and Postpartum: The VIPRiMS Score
by: Gabriel Bsteh, et al.
Published: (2022-01-01)

Metabolic Insights into Iron Deposition in Relapsing-Remitting Multiple Sclerosis via 7 T Magnetic Resonance Spectroscopic Imaging
by: Alexandra Lipka, et al.
Published: (2023-01-01)

Management of MS Patients Treated With Daclizumab – a Case Series of 267 Patients
by: Paulus S. Rommer, et al.
Published: (2020-09-01)

Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trial
by: Patrick Altmann, et al.
Published: (2022-11-01)

The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study
by: Altmann, Patrick, et al.
Published: (2021-05-01)

Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple Sclerosis
by: Nik Krajnc, et al.
Published: (2022-06-01)

Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis
by: Uwe K. Zettl, et al.
Published: (2016-01-01)

Exome-Sequence Analyses of Four Multi-Incident Multiple Sclerosis Families
by: Tobias Zrzavy, et al.
Published: (2020-08-01)

Epileptic seizures at multiple sclerosis onset and their role in disease progression
by: Matthias Grothe, et al.
Published: (2023-09-01)

Evaluation of Retinal Layer Thickness Parameters as Biomarkers in a Real-World Multiple Sclerosis Cohort
by: Schurz N, et al.
Published: (2021-03-01)

Immunosenescence in Neurological Diseases—Is There Enough Evidence?
by: Paulus S Rommer, et al.
Published: (2022-11-01)

Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis
by: Michael Hecker, et al.
Published: (2022-06-01)

Expansion of Neutrophils and Classical and Nonclassical Monocytes as a Hallmark in Relapsing-Remitting Multiple Sclerosis
by: David Haschka, et al.
Published: (2020-04-01)

Author Correction: Seven day pre-analytical stability of serum and plasma neurofilament light chain
by: Patrick Altmann, et al.
Published: (2022-04-01)

Seven day pre-analytical stability of serum and plasma neurofilament light chain
by: Patrick Altmann, et al.
Published: (2021-05-01)

Polypharmacy in patients with multiple sclerosis: a gender-specific analysis
by: Niklas Frahm, et al.
Published: (2019-05-01)

Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis
by: Michael Hecker, et al.
Published: (2023-12-01)

Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients
by: Paulus S. Rommer, et al.
Published: (2020-02-01)

Clinical scales in autoimmune encephalitis—A retrospective monocentric cohort study
by: Stefan Macher, et al.
Published: (2023-10-01)

Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis.
by: Michael Hecker, et al.
Published: (2011-01-01)

COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.
by: Gabriel Bsteh, et al.
Published: (2021-01-01)

A genetic variant associated with multiple sclerosis inversely affects the expression of CD58 and microRNA-548ac from the same gene.
by: Michael Hecker, et al.
Published: (2019-02-01)

Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MS
by: Tobias Zrzavy, et al.
Published: (2024-04-01)

Transcriptome alterations in peripheral blood B cells of patients with multiple sclerosis receiving immune reconstitution therapy
by: Michael Hecker, et al.
Published: (2023-08-01)

Relapsed/Refractory Multiple Myeloma in 2020/2021 and Beyond
by: Klaus Podar, et al.
Published: (2021-10-01)

Relapsed/Refractory Hodgkin Lymphoma
by: Semira Sheikh, et al.
Published: (2018-06-01)

Radiopharmaceuticals for Relapsed or Refractory Leukemias
by: Charles A. Kunos, et al.
Published: (2019-02-01)

Side effects following vaccination in multiple sclerosis: a prospective, multi-centre cohort study
by: Alexander Winkelmann, et al.
Published: (2023-09-01)

Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies
by: Johann Sellner, et al.
Published: (2021-01-01)

Comparison of Ifosfamide, Carboplatin and Etoposide versus Etoposide, Steroid, and Cytarabine Cisplatin as Salvage Chemotherapy in Patients with Refractory or Relapsed Hodgkin's lymphoma
by: Valiollah Mehrzad, et al.
Published: (2017-01-01)

Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: A randomised, parallel-group, controlled trial
by: Johannes Dorst, et al.
Published: (2019-11-01)

Deoxyspergualin in relapsing and refractory Wegener's granulomatosis.
by: Flossmann, O, et al.
Published: (2009)

Blinatumomab in Relapsed/Refractory Burkitt Lymphoma
by: Jeanne Bohler, et al.
Published: (2022-12-01)

Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)